Closed · RFA-IP-11-013 · CFDA 93.283 · Discretionary

Influenza Vaccine Efficacy in Tropical and Developing Countries

Federal grant opportunity posted by Centers for Disease Control and Prevention - ERA, cataloged on Grants.gov.

up to $1.3M
Award range
Closed
Status
March 14, 2011
Close date
2
Expected awards

The verdict

Influenza Vaccine Efficacy in Tropical and Developing Countries is a closed discretionary listing from Centers for Disease Control and Prevention - ERA that offered Up to $1,250,000 across 2 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 639 other opportunities from Centers for Disease Control and Prevention - ERA.

up to $1.3M
award range
Closed
application status
2
expected awards
93.283
CFDA program

Archived opportunity record

Influenza Vaccine Efficacy in Tropical and De… is closed (last close March 14, 2011). The parent program page for CFDA 93.283 is the reliable place to catch re-announcements. Centers for Disease Control and Prevention - ERA still indexes 639 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed March 14, 2011

Posted Dec 30 Closes Mar 14

Expected Awards

2

Instrument

Cooperative Agreement

Description

A limited number of studies have suggested that influenza vaccination of select groups in a population provides protection to both vaccinated and unvaccinated persons, including those who respond poorly to vaccination, by decreasing transmission within a community to susceptible persons. Few studies have been conducted to assess the indirect effects of influenza vaccination, either at the household or the community level. Apart from an observational study that was conducted during the 1968 pandemic, few data are available to evaluate the effects of influenza vaccination on rates of illness among non-vaccinated persons in a community. Furthermore, no information is available on effectiveness of vaccines in populations from tropical, developing countries, where influenza vaccine use remains limited. In these countries, differences in social interactions, population density, household composition, and school attendance could alter the transmission characteristics of influenza compared to those in the United States and other developed countries in temperate climates. As the next influenza pandemic could arise in a tropical, developing country, such information is critical to effective planning and preparedness, but will also add to the general understanding of the dynamic interplay between influenza transmission, social structure, and population immunity. Information obtained from such studies will also provide important data on strategies for the use of influenza vaccine during a pandemic, when the supply of vaccine will likely be limited. Results from these studies will also provide important information on the epidemiology and disease burden of influenza in tropical regions, and on the potential benefits of seasonal vaccination programs in developing countries.

Catch-all / unrestricted eligibility mark · RFA-IP-11-013

Grants.gov marks Influenza Vaccine Efficacy in Tropical and De… with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). This eligibility-code string dominates the Centers for Disease Control and Prevention - ERA book (299 peers, 47% of 640).

Code 25
Others (see official listing text)

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Centers for Disease Control and Prevention (CDC) Procurement and Grants Office (PGO) Technical Information and Management Section (TIMS) Phone 770-488-2700

What to do next

Influenza Vaccine Efficacy in Tropical and De… is closed; use the parent program and agency catalog for the next funding cycle.

  • Parent CFDA 93.283 may publish future NOFOs under the same assistance listing. Open program
  • Centers for Disease Control Investigations an… indexes 3 Grants.gov listings in this extract. Program profile
  • Centers for Disease Control and Prevention - ERA lists 639 other indexed opportunities on PlainGrants. Agency catalog

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants